Chemplast Sanmar Warns FY26 Challenging, FY27 CCVL Spreads Neutral

Chemplast Sanmar Limited — Q4 & FY26 Earnings Call (May 26, 2026)

1. Overall Tone of Management: Neutral (with pockets of optimism)

• Management repeatedly calls FY26 “a very challenging year” and highlights structural headwinds (dumping, geopolitical disruptions, “continued dumping of suspension PVC”, and “structural reset in the earnings outlook”).
• However, they are constructively positive on Specialty/Paste PVC and expansion execution (e.g., “remain positive on the Paste PVC business”, “progress… as planned”, “commercial production of R32… commenced”, “positive… specialty business… stronger performance”).

2. Key Themes from Management Commentary

• FY26 was dominated by commodity stress + regulatory failures
• “persistent price pressures, excess global capacities… continued dumping” and “regulatory support has weakened” (rescinding QCOs, customs duty reduction).
• Specialty Chemicals delivered growth and operational strength
• Specialty segment: “one of its strongest… quarterly sales” with “13% YoY growth” and “17% YoY volume increase” (driven by Paste PVC).
• Paste PVC outlook improved due to demand stability + potential ADD upside
• Cuddalore Paste PVC: “operated through the year at 100% of capacity”.
• ADD investigation finalized; implementation expected “during first half of FY2026, ’27” (qualitative upside).
• Custom Manufactured Chemicals (CDMO/CMC) facing near-term agrochemical slowdown
• “weakness is temporary” with “strong order book for FY27”.
• Pipeline momentum: “45-plus molecules progressing” (17 commercial).
• R32 refrigerant gas project: tangible progress
• “commercial production… has commenced recently”; commissioning expected “in phases”.
• Suspension PVC (CCVL) is the major risk center
• Market reset from war-driven VCM/PVC disconnect and continued low-priced carbide PVC flooding India.
• Accounting impact: impairment “INR898 crores” + onerous contracts/write-down “INR150 crores”.
• Management frames impairment as non-cash and liquidity-neutral, but admits spreads are only “neutral… on a replacement cost basis”.

3. Q&A Analysis

Theme A: Suspension PVC (CCVL) spreads, FY27 sustainability, and regulatory timing

• Core questions
• Q1 FY27 spread trend after onerous contracts; how to expect CCVL performance in FY27.
• Whether FY27 remains “stressful” if crude/gas stay elevated and Chinese cost advantage persists.
• Domestic demand stability and sustainability given imported VCM dependence.
• Status of ADD re-filing for China; whether filed and timing.
• Management response
• Spreads: “neutral level on a replacement cost basis”; VCM softening “may not be significant… too early”.
• Acknowledges additional contract hits: “a couple of other contracts which will hit… between May and June”.
• FY27 stress: “possible” under pessimistic assumptions, but cites hope for 7.5% duty returning end of June and Chinese producers also under stress.
• Demand: domestic demand “muted… about 1 percentage point below last year” and expected to “catch up maybe after the first quarter”.
• ADD: “working on the data… will be filing in the near future” (explicitly not filed yet).
• Feedstock risk mitigation: secured supply despite supplier declaring inability post contract; still “short-term solution” and exploring sustainable feedstock avenues.
• Evasive/partial/strong signals
• Partial: “near future” for ADD filing lacks timing precision.
• Strong admission: spreads only neutral; additional contract impacts likely in Q1/Q2.

Theme B: Paste PVC vs Suspension PVC—comparative behavior and ADD impact

• Core questions
• How Paste PVC behaves differently from Suspension PVC.
• Expected benefit magnitude from ADD and whether Paste PVC can stabilize vs ongoing EU dumping.
• Management response
• Paste PVC: smaller market, traditionally higher price, and already has antidumping on multiple countries; final findings received and import bookings from Europe slowed; expects government “fair approach”.
• Paste PVC spreads improvement is implied via ADD implementation timing, but management avoids quantitative spread guidance.
• Evasive/partial
• No numeric spread/margin uplift provided; relies on qualitative “hope/expect”.

Theme C: CDMO/CMC (Krishna) pipeline, ramp-up timing, and revenue targets

• Core questions
• Whether innovator demand is reviving; pipeline status across agchem and non-agchem.
• Whether INR1,000+ crores revenue target remains intact and timelines.
• What “45 molecules” means (commercial vs development) and opportunity size/probability.
• Management response
• Innovators: not impacted by generic pricing; issue is launch ramp delays by customers.
• Still “optimistic”; “still keep that intact” for INR1,000+ crores; “hopefully next year” to reach.
• 45 molecules: “includes 17 that are commercial”; basket growing quarter-on-quarter; customers intend to diversify supplier base.
• Opportunity size: refused to quantify LOI value (“refrain from giving guidance”).
• Evasive/partial
• Strong on qualitative confidence; refuses quantitative opportunity sizing.

Theme D: R32 go-to-market, capacity, quota risk

• Core questions
• R32 capacity by end of year; domestic vs export strategy.
• Quota allotment risk for R32 (e.g., Vietnam) and whether strategy is risky without quota clarity.
• HF sourcing logistics for R32.
• Management response
• Capacity: committed “14 kt capacity” by end of year; design debottlenecking possible.
• Go-to-market: domestic plus exploring partners for global markets.
• Quota: “government still working on it”; “strongly believe” quota allocation; timeline “by 2027”.
• HF sourcing: tied up with sources for short-term; logistics in place; own support systems possible later.
• Evasive/partial
• Quota confidence is asserted, but still no hard confirmation; relies on belief and “right to some volumes”.

Theme E: Exceptional items and impairment mechanics

• Core questions
• Nature of INR150 crores exceptional item and how Q1 should look.
• Whether impairment implies no meaningful improvement in SPVC margins in FY27/FY28.
• Management response
• INR150 crores: difference between actual cost and net realizable value; reversal expected in current financial year; “1 or 2 more consignments” may affect contribution; “breakeven” until improvement post June war situation.
• INR898 crores impairment: point-in-time estimate; margins currently “just meeting the cost, the variable cost”; impairment will be reviewed periodically if conditions improve.
• Strong signals
• Clear accounting framing: non-cash impairment; but operationally they admit margins are at variable-cost levels.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Paste PVC / Specialty
• No explicit revenue/margin guidance given.
• R32
• “by end of the year, 14 kt capacity”
• Commercial production of R32 already commenced; commissioning in phases.
• CDMO/CMC
• INR1,000+ crores revenue target: reiterated as “still keep that intact” and “hopefully next year”.
• Suspension PVC
• No numeric FY27 spread/margin guidance; only “neutral” replacement-cost spreads and “breakeven” framing in Q1 context.

Implicit signals (qualitative)

• Suspension PVC (CCVL)
• Near-term: spreads “neutral”, possible continued stress; additional contract impacts in May–June; demand “muted” but expected to improve after Q1 if geopolitics stabilizes.
• Regulatory: expects 7.5% duty to return end of June; ADD re-filing “near future”; regulatory support is “critical”.
• Specialty business
• “positive” and expects “stronger performance” in FY26’27.
• CDMO
• “weakness temporary” with strong FY27 order book; pipeline momentum continues.

5. Standout Statements (direct / highly revealing)

• Structural reset + impairment
• “created a more structural reset in the earnings outlook… reassessment… Ind AS 36.”
• “impairment loss of INR898 crores… non-cash… does not affect liquidity.”
• Suspension PVC economics
• “looking at a spread which is at a neutral level on a replacement cost basis”
• “margins today… effectively, we are just meeting the cost, the variable cost”
• Near-term contract overhang
• “there could be uncertainties… a couple of other contracts which will hit… between May and June.”
• R32 execution
• “commercial production of R32… has commenced recently”
• “by the end of the year… 14 kt capacity”
• CDMO confidence
• “we believe the current weakness is temporary in nature”
• “strong order book for FY27”
• “still keep that intact” (INR1,000+ crores revenue target)
• Regulatory stance
• ADD/QCO importance: “regulatory support… very critical” (medium-to-long term for Suspension PVC).

6. Red Flags / Positive Signals

Red flags
– Commodity business deterioration is no longer just “cycle”—it’s “structural reset” with large impairment.
– Suspension PVC remains at variable-cost economics (“just meeting the cost”).
– Regulatory dependence remains high (ADD/QCO/duty timing drives outlook; ADD filing not yet done).
– Quota strategy relies on belief/confidence, not confirmed allotment (“strongly believe… should be getting the quota”).

Positive signals
– Specialty/Paste PVC operational execution: “100% capacity” at Cuddalore; volumes up.
– CDMO pipeline momentum: 45+ molecules progressing; 17 commercial; customers diversifying supplier base.
– R32 project de-risking: commercial production started; capacity timeline reiterated.

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

a. Change in Tone Over Time

• Q1 FY26 (Jul 2025): optimistic about ADD outcomes and “green shoots”; expected ADD by Q3; “near end of a long winter”.
• Q2 FY26 (Nov 2025): still challenging but improving sequentially; confidence in capacity commissioning and medium-term balance via rationalization.
• Q3 FY26 (Feb 2026): more cautious—regulatory setbacks (ADD not accepted; QCO rescinded); still believed Q3 was “bottom” and uptrend visible.
• Q4 & FY26 (May 2026): more cautious/neutral—management explicitly states “structural reset”, impairment of INR898 crores, and admits Suspension PVC spreads only neutral/variable-cost level.
• Shift classification: More Cautious (stronger emphasis on accounting impairment + weakened regulatory support; less confidence on near-term commodity recovery).

b. Tracking Past Commitments vs Outcomes

• CDMO revenue target (INR1,000 crores by FY27)
• Past (Nov 2025 / Feb 2026): guidance held but “delay by a few quarters”; still “comfortable”.
• Current (May 2026): “still keep that intact” and “hopefully next year” → ⏳ Delayed but still on track narrative.
• Suspension PVC regulatory expectation (ADD/QCO)
• Past (Q1 FY26 / Q2 FY26): expectation that ADD would come; QCO/BIS enforcement expected.
• Current: regulatory support “weakened” (QCO rescinded; customs duty reduced till June); ADD re-filing not yet filed.
• Outcome: ❌ Missed / Dropped on timing and certainty; regulatory measures did not arrive as hoped.
• R32 capacity ramp
• Past (Nov 2025 / Feb 2026): swing plant commissioning and capacity planning; quota clarity expected around 2027.
• Current: commercial production commenced; “14 kt by end of year” → ✅ Delivered on execution progress (quota still not confirmed, but project momentum is real).

c. Narrative Shifts

• Commodity story moved from “cycle + regulatory delay” to “structural reset + impairment”
• Earlier calls leaned on “green shoots” and expected ADD/QCO outcomes.
• Now management explicitly ties earnings outlook reset to war-driven VCM/PVC disconnect and regulatory withdrawal.
• Specialty story remains consistent
• Paste PVC operational strength and Specialty growth narrative persists across calls.
• Regulatory emphasis intensifies
• From “ADD/QCO pending” to “regulatory support has weakened” and “ADD is the only long-term solution (WTO compliant)”—a more defensive stance.

d. Consistency & Credibility Signals

• Medium credibility
• Positives: R32 execution appears to be progressing as planned; CDMO pipeline claims are consistent.
• Concerns: repeated regulatory timing hopes (ADD/QCO/BIS) have not materialized as expected; management now uses more “structural reset” language and less quantitative certainty.

e. Evolution of Key Themes

• Demand
• PVC demand: from “robust/returning” (Q1/Q2) to “muted” (Q4) with improvement only after Q1 if geopolitics stabilizes.
• Margins
• Suspension PVC: from “breakeven/comfort zone” (earlier) to “neutral replacement spread” and “meeting variable cost”.
• Expansion
• Specialty/Paste PVC: consistently positive execution.
• CDMO: consistent pipeline momentum; ramp delays acknowledged.
• R32: increasingly concrete milestones (commercial production now).
• Regulation
• Persistent theme, but outcomes have worsened vs earlier expectations (QCO rescinded; customs duty reduced; ADD implementation delayed/uncertain).

f. Additional Insights (cross-period intelligence)

• Impairment + “non-cash” framing suggests management is trying to separate liquidity from earnings power—yet Q&A confirms operational economics are still weak (variable-cost level). This implies earnings recovery is not imminent even if cash is protected.
• ADD reliance is shifting from “expected implementation” to “re-filing/near future”, indicating regulatory timelines have slipped materially.
• CDMO optimism is holding despite agrochemical slowdown, but management still avoids quantifying LOI value—suggesting upside exists, but conversion to revenue remains uncertain.